• 29-Oct-2026 Cyclopharm Q3 2026 Update Cyclopharm Q3 2026 Update
• 27-Oct-2026 Cyclopharm Q3 Investor Update Webinar Cyclopharm Q3 Investor Update Webinar
• 26-Oct-2026 Retirement of Non-Executive Director Dianne Angus Retirement of Non-Executive Director Dianne Angus
• 12-Oct-2026 Change in substantial shareholding from AEF Change in substantial shareholding from AEF
• 7-Oct-2026 Chinese Consensus Names Technegas Preferred Lung Agent Chinese Consensus Names Technegas Preferred Lung Agent
• 24-Aug-2026 Cyclopharm 1H 2026 Results Webinar Cyclopharm 1H 2026 Results Webinar
• 24-Aug-2026 CYC 1H2026 Results Summary CYC 1H2026 Results Summary
• 24-Aug-2026 Half Yearly Report and Accounts Half Yearly Report and Accounts
• 29-Jul-2026 New US Lung Imaging Guidelines Name Technegas as Preferred A New US Lung Imaging Guidelines Name Technegas as Preferred A
• 28-Jul-2026 ausbiz TV Presentation ausbiz TV Presentation
• 15-Jul-2026 Immediate 11-Site Technegas Rollout at University Hospitals Immediate 11-Site Technegas Rollout at University Hospitals
• 6-Jul-2026 Notification of cessation of securities - CYC Notification of cessation of securities - CYC

Click here for archives